Survey infographic: benefits and challenges of biomarker studies for oncology drug development

In partnership with Frontage Laboratories (PA, USA), we conducted a survey exploring the types of biomarkers being used in oncology today, the types of cancers that could benefit most from biomarker studies, the platforms being used to perform biomarker assays and the benefits and drawbacks of biomarker assays in oncology drug development and personalized medicine.

We’ve captured the key takeaways from the survey in this handy infographic and discuss these results in more detail during our Spotlight panel discussion.

BZ Q3 Spotlight infographic Oncology Drug Development_compressed

[Illustrated by Tobias Dumbraveanu]

In association with: